---
title: "Investigation into VYNE Therapeutics Inc. for possible breaches of fiduciary duty in transaction with Yarrow Bioscience."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/270231144.md"
description: "In Milwaukee on December 18, 2025, The Ademi Firm announced an investigation into VYNE (Nasdaq: VYNE) regarding potential breaches of fiduciary duty and legal violations related to its recent deal with Yarrow Bioscience. Individuals interested in participating in the investigation and gaining further information can access details by clicking the provided link."
datetime: "2025-12-19T00:41:59.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/270231144.md)
  - [en](https://longbridge.com/en/news/270231144.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/270231144.md)
---

# Investigation into VYNE Therapeutics Inc. for possible breaches of fiduciary duty in transaction with Yarrow Bioscience.

In Milwaukee on December 18, 2025, The Ademi Firm announced an investigation into VYNE (Nasdaq: VYNE) regarding potential breaches of fiduciary duty and legal violations related to its recent deal with Yarrow Bioscience. Individuals interested in participating in the investigation and gaining further information can access details by clicking the provided link.

### Related Stocks

- [VYNE.US](https://longbridge.com/en/quote/VYNE.US.md)

## Related News & Research

- [Vyne Therapeutics publishes Yarrow Bioscience investor presentation factsheet](https://longbridge.com/en/news/287273372.md)
- [VALION BIO BRIEFS SENIOR DEPARTMENT OF WAR AND BARDA OFFICIALS IN JOINT ENGAGEMENT ON ENTOLIMOD FOR ACUTE RADIATION SYNDROME | VBIO Stock News](https://longbridge.com/en/news/286964504.md)
- [Kyntra Bio Rocked by CEO’s Sudden Insider Stock Sale](https://longbridge.com/en/news/286847501.md)
- [Activist Elliott Takes Major Stake in Bio-Rad — Can It Boost BIO Stock Price?](https://longbridge.com/en/news/286737807.md)
- [Climb Bio Teases Key Budoprutug, CLYM116 Readouts at BioConnect](https://longbridge.com/en/news/287158920.md)